




Searching News Database: renal denervation
HSMN NewsFeed - 13 Jul 2022
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
HSMN NewsFeed - 13 May 2022
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
HSMN NewsFeed - 5 Jan 2018
ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study
ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study
HSMN NewsFeed - 31 Oct 2016
ReCor Medical Announces Key Milestones in RADIANCE-HTN Hypertension Clinical Study
ReCor Medical Announces Key Milestones in RADIANCE-HTN Hypertension Clinical Study
HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
HSMN NewsFeed - 28 Jan 2014
ReCor Medical Announces Major Advances with Its Ultrasound-Based Renal Denervation System
ReCor Medical Announces Major Advances with Its Ultrasound-Based Renal Denervation System
HSMN NewsFeed - 17 May 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
HSMN NewsFeed - 30 May 2012
Kona Medical Secures $30M in Financing to Pursue Novel Hypertension Therapy
Kona Medical Secures $30M in Financing to Pursue Novel Hypertension Therapy
HSMN NewsFeed - 16 May 2012
Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure
Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure
HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
HSMN NewsFeed - 12 Apr 2012
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
HSMN NewsFeed - 4 Nov 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
HSMN NewsFeed - 7 Apr 2011
Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization
Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization